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278–79	(2016).	For	a	discussion	of	what	 is	 required	 to	meet	each	of	 these	require-
ments,	see	generally	infra	note	8.	While	every	patent	application	is	examined	by	the	
















nopolize	 technology	that	should	otherwise	remain	 in	 the	public	do-
main.	Recognizing	the	threat	that	invalid	patents	pose,	Congress	es-



































§	2131	 (9th	 ed.	 2018)	 [hereinafter	 MPEP].	 Nonobviousness	 assesses	 whether	 the	


















Article	 III	 standing	 requirements—suffering	 an	 injury	 in	 fact.	Mere	
participation	in	the	agency	proceeding	is	not	enough.11	In	the	majority	
of	 IPR	appeals,	 this	 is	not	an	 issue	because	 the	patent	challenger	 is	








patent	 challenger	 to	 infringe	 the	 patent	 and	 risk	 treble	 damages	
and/or	an	injunction	to	satisfy	the	injury	in	fact	requirements.15		
This	Note	argues	that,	to	better	align	with	Congress’s	intent	and	































lowing	 competitors	 to	proceed	with	 their	 appeal	 of	 an	 adverse	 IPR	
decision.		
Part	I	of	this	Note	discusses	the	patent	examination	process	and	




preme	 Court’s	 articulation	 of	 the	 Article	 III	 standing	 requirements.	
Part	II	then	argues	that	the	Federal	Circuit’s	current	interpretation	of	
the	injury	in	fact	requirement	for	patent	challengers,	specifically	non-












ber	 of	 invalid	 patents,	 mitigating	 the	 negative	 effects	 such	 patents	



























infringement	 damages.	 This	 phenomenon	 can	 stifle	 innovation.	 To	
help	alleviate	this	potential	problem,	Congress	established	the	Patent	
Trial	and	Appeal	Board	to	assess	the	validity	of	some	of	these	patents	




















	 21.	 See	 U.S.	 GOV’T	 ACCOUNTABILITY	 OFF.,	 INTELLECTUAL	 PROPERTY:	 PATENT	 OFFICE	
SHOULD	DEFINE	QUALITY,	REASSESS	INCENTIVES,	AND	IMPROVE	CLARITY	37–39	(2016)	[here-
inafter	2016	ACCOUNTABILITY	REPORT].	
	 22.	 The	 “patent	 thicket”	 is	 “a	 dense	 web	 of	 overlapping	 intellectual	 property	
rights	that	a	company	must	hack	its	way	through	in	order	to	actually	commercialize	
new	 technology.”	Carl	 Shapiro,	Navigating	 the	Patent	Thicket:	Cross	Licenses,	Patent	
Pools,	and	Standard	Setting,	1	INNOVATION	POL’Y	&	ECON.	119,	120	(2000).	


































































an	 applicant’s	 specification	 (which	 can	 be	more	 than	 one	 hundred	
pages),	searching	the	prior	art,33	 formulating	and	writing	any	rejec-
tions	to	the	application,34	conducting	interviews	with	the	applicant’s	













































patentability	 requirements.	 A	 PTO	 review	 of	 its	 quality	 assurance	
practices	concluded	that	around	four	percent	of	patent	examinations	
included	“unreasonable	failure[]	by	the	patent	examiner	to	reject	pa-










































than	the	costs	of	obtaining	the	patent	 in	 the	 first	place.44	The	value	
stems	 from	the	possibility	 that,	even	 if	 invalid,	a	court	or	 the	PTAB	
may	 uphold	 the	 validity	 of	 the	 patent.45	 This	 provides	 the	 patent	





























	 49.	 Alberto	 Galasso	 &	Mark	 Schankerman,	Patents	 and	 Cumulative	 Innovation:	
Causal	Evidence	 from	the	Courts	19	(Nat’l	Bureau	of	Econ.	Rsch.,	Working	Paper	No.	
20,269,	 2014).	The	 researchers	 examined	 the	number	of	 times	 that	 the	patent	was	





















argued,	because	so	 few	patents	are	 later	commercially	valuable,	 for	
the	Patent	Office	 to	expend	 the	 resources	 to	 conduct	a	more	 “thor-
ough”	examination,	and	issue	fewer	invalid	patents,	would	not	justify	






In	 2011,	 through	 the	 Leahy-Smith	 America	 Invents	 Act	 (AIA),	
Congress	established	the	inter	partes	review	proceeding	after	recog-
nizing	 “that	 questionable	 patents	 [were]	 too	 easily	 obtained	 and	
[were]	 too	difficult	 to	 challenge.”55	With	 this	 new	proceeding,	 Con-
gress	sought	to	“broade[n]	participation	rights”	of	third-party	patent	
 











more	 thorough	 examination	 with	 longer	 time-allotments	 per	 application,	 the	 fees	
would	inevitably	increase	accordingly.	See	also	USPTO	2020	JUSTIFICATION,	supra,	at	17	
(“The	USPTO	continues	to	conduct	biennial	fee	reviews	to	ensure	fees	are	aligned	with	

















































































































to	 appeal,	 Congress	 achieved	 its	 goal	 of	 increasing	 participation	 in	
seeking	to	invalidate	low-quality	patents.74	
1. Any	Third	Party	May	Petition	to	Institute	an	IPR	Before	the	PTAB	




tent	 challenger)	must	 first	 file	 a	 petition	with	 the	 Patent	 Office	 re-
questing	the	cancellation	of	one	or	more	claims	of	another’s	granted	
patent.75	After	receiving	the	petition,	the	Patent	Office	reviews	the	pe-
tition	 and	determines	whether	 it	 “shows	 that	 there	 is	 a	 reasonable	


























































































eral	 Circuit’s	 current	 interpretation	 of	 standing	 in	 IPR	 appeals	 se-
verely	restricts	the	challenges	brought	by	direct	competitors.	The	Fed-



































able	 to	 use	 the	 patented	 technology	 and	 face	 a	 continual	 threat	 of	














































































































	 108.	 Id.	at	575	(“[T]o	entitle	a	private	 individual	 to	 invoke	the	 judicial	power	to	
determine	the	validity	of	executive	or	legislative	action	he	must	show	that	he	has	sus-









	 112.	 See	 JTEKT	 Corp.	 v.	 GKN	 Auto.	 Ltd.,	 898	 F.3d	 1217,	 1221	 (Fed.	 Cir.	 2018)	
(“[W]here	the	party	relies	on	potential	 infringement	 liability	as	a	basis	 for	 injury	 in	




















tablish	Article	 III	 standing.116	As	discussed	 in	 the	next	 section,	 con-





tent,	 and	 a	 second,	 then-pending,	 Genentech	 patent	 application.118	








miss	 MedImmune’s	 declaratory	 action,	 arguing	 that	 because	























risk	 treble	 damages	 .	.	.	 finds	 no	 support	 in	 Article	 III.”125	 In	 other	
words,	the	Supreme	Court	established	that	a	patent	challenger	need	
not	 actively	 infringe	 the	 challenged	patent,	 exposing	 itself	 to	 treble	
damages	and	an	injunction,	to	be	able	to	challenge	the	validity	of	an	
issued	patent	 in	 the	 courts.126	 Under	 its	 current	 interpretation,	 the	





ton	 International,	 Inc.,	 the	 Court	 recognized	 that	 in	 some	 circum-
stances,	even	when	a	patent	challenger	is	no	longer	at	risk	of	an	in-





























































































































establish	 an	 injury	 in	 fact	 following	 an	 adverse	 IPR	 decision	 is	 by	
showing	that	 it	 is	actively	 infringing	 the	patent	and	 is	subject	 to	an	
infringement	suit.145	It	is	estimated	that	around	eighty	percent	of	the	
IPR	petitions	filed	each	year	are	filed	in	response	to	assertions	of	in-
fringement	 in	 district	 court	 litigation.146	 Instead	 of	 going	 through	
costly	litigation	in	district	court,	the	patent	challenger	may	opt	to	chal-
lenge	the	validity	in	an	IPR,147	helping	to	expedite	litigation.148	But	if	





	 145.	 See,	 e.g.,	 Aylus	Networks,	 Inc.	 v.	 Apple	 Inc.,	 856	F.3d	1353,	 1358	 (Fed.	 Cir.	
2017)	(“Aylus	sued	Apple	for	infringement	of	the	’412	patent.	Apple	then	filed	two	sep-
arate	petitions	for	 inter	partes	review	with	the	Patent	Trial	and	Appeal	Board,	each	





































































tioner	must	show	that	it	 is	engaged	or	will	 likely	engage	 ‘in	an[]	activity	that	would	
give	rise	to	a	possible	infringement	suit.’”	(quoting	Consumer	Watchdog	v.	Wis.	Alumni	
Rsch.	Found.,	753	F.3d	1258,	1262	(Fed.	Cir.	2014))).		














mercial	activities	 involving’	 the	claimed	subject	matter	of	 the	[chal-
lenged]	patent,”	it	still	met	the	injury	in	fact	requirements.158	Properly	
following	 Supreme	 Court	 precedent,	 the	 Federal	 Circuit	 concluded	
that	DuPont	adequately	established	 its	 injury	 in	 fact	because	 it	had	
concrete	“plans	to	take	.	.	.	action	that	would	implicate	the	[challenged]	
patent.”159		





































substantial	 risk”	 of	 infringing	 the	 challenged	patent.164	 The	Federal	
Circuit	 formed	this	conclusion	 largely	on	 JTEKT’s	concession	 that	 it	
had	not	yet	 finalized	 its	design	which	 it	 asserted	posed	a	direct	 in-




dinal	Chemical.167	 If	 the	Federal	Circuit	provided	an	 invalidity	 judg-
ment,	then	JTEKT	could	incorporate	the	patent’s	technology	in	its	de-
sign	 without	 risk	 of	 future	 infringement	 damages.	 While	 JTEKT’s	






for	 infringement,	 to	satisfy	 the	concrete	and	particularized	require-
ments	of	asserting	an	injury	in	fact,	under	the	Federal	Circuit’s	current	





















	 170.	 See	 JTEKT	Corp.,	898	F.3d	at	1221	(“[The	patent	challenger]	must	establish	

















an	 allegedly	 invalid	 patent	 in	 Cardinal	 Chemical.174	 AVX	 submitted	
several	declarations	detailing	the	competitive	nature	of	the	two	com-












the	United	 Technologies	 (UTC)	 patent,	 and	 second,	 that	 as	 a	 direct	


























facturers	 directly	 competing	 with	 UTC,	 UTC’s	 patent	 impeded	 its	
ability	to	use	its	own	1970s	turbofan	engine	design	as	a	basis	to	de-
velop	 its	 future	designs.183	GE	asserted	 that	 this	 forced	 it	 to	design	
around	UTC’s	patent,	“restrict[ing]	GE’s	design	choices”	and	forcing	it	
to	“incur	additional	research	and	development	expenses.”184	But	the	
Federal	Circuit	 again	 concluded	 that	 this	 failed	 to	establish	an	ade-
quate	injury	in	fact	because	GE	must	still	have	a	“nonspeculative	in-






to	establish	Article	 III	standing.	As	currently	 interpreted,	 for	a	non-
infringing	direct	competitor	to	adequately	establish	 its	standing	be-
fore	the	court,	it	must	“allege[]	current	or	nonspeculative	activities	of	















































crease	 the	 strength	 of	 the	 U.S.	 patent	 system	 for	 patent	 owners.187	
Many	of	the	Federal	Circuit’s	decisions	succeeded	in	doing	just	this.	
However,	 like	 several	 of	 the	 Federal	 Circuit’s	 other	 decisions	 later	
overturned	by	the	Supreme	Court	for	being	overly	restrictive	on	pa-




	 187.	 See	Robert	P.	Merges,	One	Hundred	Years	of	Solicitude:	 Intellectual	Property	
Law,	1900-2000,	88	CALIF.	L.	REV.	2187,	2224	(2000)	(“[T]he	creation	of	 the	Federal	
Circuit	had	a	clear	substantive	agenda:	to	strengthen	patents.”).	





































































that	 the	 patent	 is	 invalid	 under	 novelty	 and	 nonobviousness	








































lengers,	 the	 Federal	 Circuit	 allows	 the	 allegedly	 invalid	 patent	 to	
“serve[]	as	a	head	on	a	pike,”	and	prevent	any	researcher,	inventor,	or	
manufacturer	from	using	the	technology.198		




































owner	 confers	 to	 the	 licensee,	whether	 it	 is	 an	 exclusive	 license	 or	
merely	a	 license	 to	use.203	 Lastly,	 the	party	 could	 ignore	 the	patent	
owner’s	patent	altogether	and	practice	the	invention	for	themselves	





the	 Patent	 Office	 issues	 an	 invalid	 patent,	 that	 concrete	 injury	 be-
comes	more	pronounced	because	a	direct	competitor	would	be	able	
to	practice	the	patented	invention	but	for	the	Patent	Office’s	error.208	






























































































































































to	determine	prior	art	 is	 analogous.	See	 In	 re	 Clay,	966	F.2d	656,	658–59	 (Fed.	Cir.	
1992)	(applying	the	“field	of	endeavor”	criteria	to	applicant’s	gelation	solution).	
	 220.	 See	In	re	Bigio,	381	F.3d	at	1325–26;	In	re	Clay,	966	F.2d	at	659.	




















































tially	 the	 same	way	 to	obtain	 the	 same	result.”	Graver	Tank	&	Mfg.	Co.	v.	Linde	Air	
Prods.	Co.,	339	U.S.	605,	608	(1950)	(citing	Sanitary	Refrigerator	Co.	v.	Winters,	280	
U.S.	30,	42	(1929)).	However,	this	inquiry	is	too	narrow	because	if	a	competitor	does	








































patent	 rights	 by	 seeking	 royalties	 from	 potentially	 infringing	 parties.	 See	 Kailash	
Choudhary	&	Priyanka	Rastogi,	Non	Practicing	Entities	(NPEs)	and	Their	Impacts,	LEX-







































	 240.	 Cf.	 David	 Kwok,	Determining	 Standing	 and	 Damages	 for	 Competitive	 Injury	
from	False	Patent	Marks,	17	VA.	J.L.	&	TECH.	171,	179–81	(2012)	(noting	that	in	the	con-
















ular	 Pathology	 v.	 Myriad	 Genetics,	 569	 U.S.	 576,	 589	 (2013);	 then	 quoting	 Mayo	

















and	 recognizable	 harm.	 With	 over	 300,000	 patents	 issued	 every	
year,246	competitors	working	in	the	same	field	of	endeavor	and	solving	
similar	 problems	 with	 similar	 solutions	 will	 have	 to	 expend	 some	



















	 246.	 USPTO	 Grant	 Rates,	 PAT.	 BOTS,	 https://www.patentbots.com/stats/uspto	
-grant-rates	[https://perma.cc/7JQR-LWDL].	
	 247.	 See	Shapiro,	supra	note	22,	at	120	(noting	that	a	company	must	“hack	its	way	


























the	 preclusive	 injury	 the	 patent	 challenger	 suffers	 and	 the	 patent	






plaintiff’s	asserted	 injury	 in	 fact.	Upon	appeal,	 if	 the	Federal	Circuit	















































verse	 decision	 in	 its	 IPR	 challenging	 one	 of	 Company	 G’s	 modern	









































































an	 injury	 in	 fact	 sufficient	 to	meet	 the	 Article	 III	 standing	 require-
ments.		
JTEKT	and	GKN	both	manufacture	drivetrain	systems	for	the	au-




















	 269.	 See	 Products,	 JTEKT	 N.A.	 CORP.,	 https://jtekt-na.com/products	 [https://	






















However,	 under	 the	DCS	 Test,	 since	 this	 is	merely	 a	 patent,	 JTEKT	
must	additionally	establish	that	it	has	a	pre-existing	design	or	one	con-
cretely	under	development	which	incorporates	the	technology	of	the	
’492	 patent.	 JTEKT	 likely	 satisfies	 this	 requirement	 based	 on	 testi-
mony	by	one	of	 its	patent	engineers,	 though	 the	exact	design	plans	
were	under	seal	to	protect	JTEKT’s	intellectual	property	interests.280	
Specifically,	JTEKT’s	designs	sought	to	efficiently	shift	the	automotive	
drivetrain	between	a	 two-wheel	drive	 state	 and	a	 four-wheel	drive	
state	without	 the	use	of	 a	differential.281	However,	 instead	of	using	
side-shaft	couplings	like	GKN’s	challenged	’440	patent,	JTEKT	sought	
to	use	twin	clutches.282	Thus,	JTEKT	was	likely	solving	similar	prob-
lems	 using	 similar	 solutions	with	 its	 pre-existing	 designs	 or	 at	 the	
















	 280.	 See	 JTEKT	 Corp.	 v.	 GKN	 Auto.	 Ltd.,	 898	 F.3d	 1217,	 1221	 (Fed.	 Cir.	 2018)	
(“‘[T]he	general	features	of	JTEKT’s	current	concepts	[are]	similar	enough	to	the	fea-



























The	 DCS	 Test,	 while	 expansive,	 ensures	 that	 the	 patent	 chal-
lenger’s	injury	is	sufficiently	particularized	and	concrete	such	that	it	




























ited	 amount	 of	 time	 to	 review	 applications.290	 In	 establishing	 inter	
partes	review,	Congress	sought	to	help	alleviate	the	negative	effects	of	
any	potential	invalid	patents.291	Congress	recognized	the	injurious	ef-




petitors	 standing	 when	 appealing	 adverse	 IPR	 decisions.	What	 the	






lenged	patent,	 and	 (2)	has	pre-existing	designs	which	 solve	 similar	
problems	with	similar	solutions.	These	two	requirements	recognize	
that	a	patent	challenger	faces	a	concrete	and	particularized	injury	by	
expending	resources	to	avoid	the	patent	and	is	the	one	subject	to	the	
preclusive	effect	of	a	patent	despite	not	actively	infringing	the	patent.	
Such	injuries	should	be	sufficient	to	establish	an	injury	in	fact	and	con-
fer	Article	III	standing	on	patent	challengers	directly	competing	in	the	
technology	of	the	challenged	patent.293	By	utilizing	the	DCS	Test,	the	
Federal	Circuit	will	properly	adhere	to	Congress’s	desire	to	better	al-
low	competitors	to	challenge	invalid	patents,294	opening	up	technol-
ogy	that	should	otherwise	remain	available	for	public	use.	Only	then	
will	the	patent	system	truly	ensure	that	only	those	who	innovate	and	
push	forward	science	and	the	useful	arts	may	obtain	and	keep	their	
patents.	
	
 
	 290.	 See	supra	notes	19–21	and	accompanying	text	(noting	the	Patent	Office’s	dif-
ficulties	in	always	issuing	quality,	valid	patents).	
	 291.	 See	supra	notes	2–6	and	accompanying	text	(identifying	Congress’s	purpose	
in	establishing	IPR).	
	 292.	 See	supra	Part	I.C	(discussing	in	greater	depth	Congress’s	motivations	in	es-
tablishing	IPR).	
	 293.	 See	supra	Part	II.A	(noting	current	Article	III	standing	requirements	and	their	
application	by	the	Federal	Circuit	in	IPR	appeals).	
	 294.	 See	supra	Part	I.C.	
